Application 207619

Type
ANDA
Sponsor
BRECKENRIDGE PHARM

Related Records

Application Products

ProductDrugIngredientFormStrengthReference drugReference standard
001CABAZITAXELCABAZITAXELSOLUTION;INTRAVENOUS60MG/1.5ML (40MG/ML)NoNo

Documents

DocumentSubmission typeDate
55238ORIG2018-08-20